
Kermode Biotechnologies is an animal health company focused on combating the African Swine Fever Virus (ASFV) through AI-driven vaccine and antibody development. Leveraging computational approaches to identify viral targets, they utilize state-of-the-art antibody discovery platforms to create therapeutic candidates. Their mission is to safeguard global swine populations and support farmers by providing effective vaccines with strong, long-lasting immune responses. The company has a global outlook, with roots in New York and Shenzhen, aiming to protect livestock and enhance food security.

Kermode Biotechnologies is an animal health company focused on combating the African Swine Fever Virus (ASFV) through AI-driven vaccine and antibody development. Leveraging computational approaches to identify viral targets, they utilize state-of-the-art antibody discovery platforms to create therapeutic candidates. Their mission is to safeguard global swine populations and support farmers by providing effective vaccines with strong, long-lasting immune responses. The company has a global outlook, with roots in New York and Shenzhen, aiming to protect livestock and enhance food security.